NCT02229461View on ClinicalTrials.gov

Naproxen Sodium/ASA Platelet Study

PHASE1CompletedINTERVENTIONAL

Enrollment

117

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions

Hematology

Interventions

DRUG

Naproxen Sodium (Aleve, BAY117031)

Naproxen sodium 220 mg qd or bid

DRUG

Acetylsalicylic Acid (Aspirin, BAYE4465)

ASA 81 mg qd

Trial Locations (1)

78744

Austin

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Bayer

INDUSTRY

NCT02229461 - Naproxen Sodium/ASA Platelet Study | Biotech Hunter | Biotech Hunter